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MetastasisDDX3, a DEAD box protein family member, appears to promote the progression of some cancers, which may
partly result from its impedance of death receptor-mediated apoptosis. We found that another mechanism by
which DDX3 may aid cancer progression is by promoting increased levels of the transcription factor Snail.
Snail represses expression of cellular adhesion proteins, leading to increased cell migration and metastasis of
many types of cancer. Knockdown of DDX3 levels by shRNA reduced basal levels of Snail in HeLa and MCF-7
cells, and this was associated with reduced cell proliferation and migration. Snail protein and mRNA levels
were increased by treatment with the HDAC inhibitors sodium butyrate or trichostatin A, and these increases
were attenuated in cells with DDX3 knocked down. Treatment of cells with camptothecin was discovered to
increase Snail protein levels, and this increase was diminished in cells with DDX3 knocked down. Analysis of
31 patient glioblastoma multiforme (GBM) samples revealed a signiﬁcant correlation between the levels of
DDX3 and Snail. Thus, DDX3 is required for basal Snail expression and increases in Snail induced by HDAC
inhibitors or camptothecin, indicating that this action of DDX3 may contribute to its promotion of the
progression of some cancers.and Behavioral Neurobiology,
sity of Alabama at Birmingham,
23; fax: +1 205 934 2500.
ll rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Snail is a rapidly turning-over transcription factor that has been
shown to be a particularly important regulator of the development
and progression of cancer [1]. These actions derive from the essential
role of Snail in driving epithelial–mesenchymal transition (EMT), a
crucial process in embryonic development [2] that also promotes
cancer metastasis [3,4]. A key underlying mechanism for this effect is
that Snail suppresses the expression of several cellular adhesion
proteins, such as E-cadherin [3,4]. Suppression by Snail of E-cadherin
expression is associated with EMT, which promotes the invasive
phase of carcinoma [5,6].
Despite these crucial actions of Snail, few mechanisms that
regulate Snail have been identiﬁed. One regulatory mechanism is
the phosphorylation of Snail by glycogen synthase kinase-3β (GSK3β)
at two sites, one promoting nuclear export of Snail, which is mediated
by a CRM1-dependent mechanism [7], and the other site promoting
Snail ubiquitination that leads to its degradation by the proteasome
[8]. Conversely, Snail levels are increased by treatment of cells with
inhibitors of GSK3 or with histone deacetylase (HDAC) inhibitors [9],
and γ-irradiation stabilizes Snail by inhibiting its nuclear export [10].Considering the critical actions of Snail in development and cancer, it
is crucial to gain a better understanding of cellular mechanisms that
regulate Snail.
Recently, several ﬁndings linked cancer progression to DDX3,
a member of the DEAD box family of proteins named for a conserved
D-E-A-D sequence [11,12]. There is limited knowledge about the
functions of DDX3, which was originally linked to actions of the
hepatitis C and human immunodeﬁciency viruses [13–15]. DDX3 is a
nucleo-cytoplasmic shuttling protein [14,16] that can associate with
the Sp1 transcription factor in the nucleus and contribute to
regulating cyclin D1 and p21 levels [17,18]. Evidence that DDX3
may promote cancer includes reports that DDX3 levels are increased
in hepatocellular carcinomas [19], carcinogen treatment of MCF cells
increased DDX3 levels [20], and DDX3 impedes death receptor-
induced apoptosis [21]. These ﬁndings raised the possibility that
DDX3 may have regulatory inﬂuences on the development, progres-
sion, or treatment of certain cancers. Furthermore, recent ﬁndings
that overexpression of DDX3 induced EMT [20] and that DDX3
associates with the Snail regulator GSK3β [21] prompted us to
examine if DDX3 has a role in modulating Snail.
Herein we report that knocking down the cellular level of DDX3
reduced basal Snail levels and the increase in Snail expression induced
by HDAC inhibitors. Furthermore, Snail levels also were found to be
increased by the topoisomerase inhibitor camptothecin, and this
increase in Snail was dependent on DDX3. Furthermore, the levels of
DDX3 and Snail were signiﬁcantly correlated in a panel of glioblastoma
Table 1
Characteristics of GBM donors.
Gender American
Indian or
Alaskan
native
Asian or
Paciﬁc
Islander
Black,
not of
Hispanic
origin
Hispanic White,
not of
Hispanic
origin
Other or
unknown
Total
Female 0 0 2 0 10 0 12
Male 0 0 1 0 13 5 19
Unknown 0 0 0 0 0 1 1
Total 0 0 3 0 23 5 32
Fig. 1. Treatment with HDAC inhibitors increases Snail expression levels. (A) Comparison
of Snail levels in GM0637, HEK293, MCF-7, MDA-MB-231, CWR22RV1, LNCAP, HCT116,
HeLa, SKOV-3 cells. (B) HeLa cells or (C) MDA-MB-231 cells were treated with 5 mM
valproic acid (VPA), 5 mM nicotinamide (Ni), 5 mM sodium butyrate (NaBu), 1 μM
trichostatin A (TSA), or nicotinamide with trichostatin A for 3 h. Nuclear fractions were
prepared andSnail andCREBweremeasuredby immunoblot analysis. Lightﬁlmexposures
were used to allow detection of up-regulated levels of Snail following treatments with
HDAC inhibitors. (D) HeLa cells were pretreated with cycloheximide (CHX; 40 μg/ml) for
1 h, followed by NaBu or TSA treatment for 3 h, and Snail, DDX3, and β-actin levels were
immunoblotted. (E) Snail and 18S mRNA levels were measured in HeLa, SH-SY5Y, and
MCF-7 cells after treatment with VPA, NaBu, or TSA for 3 h.
439M. Sun et al. / Biochimica et Biophysica Acta 1813 (2011) 438–447multiforme (GBM) tumor samples. These ﬁndings suggest that DDX3
may promote cancer progression in part by supporting Snail expression.
2. Materials and methods
2.1. Cell culture and materials
HeLa and MDA-MB-231 cells were grown in Dulbecco's modiﬁed
Eagle medium (DMEM) supplemented with 10% fetal bovine serum
(Invitrogen, Carlsbad, CA), 100 U/ml penicillin, 100 μg/ml streptomy-
cin, and 15 mM HEPES, in humidiﬁed, 37 °C chambers with 5% CO2.
MCF-7 cells were grown in the same conditions as HeLa cells with the
addition of 10 μg/ml insulin. Human neuroblastoma SH-SY5Y cells
were grown in 50%MinimumEssentialMediumEagle (MEM) (Cellgro,
Herndon, VA) and 50% Kaighn's Modiﬁcation of Ham's F-12 (ATCC)
supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and
100 μg/ml streptomycin. Nuclei were extracted from cells using a
nuclear extraction kit according to the manufacturer's instructions
(ActiveMotif, Carlsbad, CA). Cell proliferationwasmeasured using the
CellTiter 96R AQueous one solution cell proliferation kit according to
the manufacturer's protocol (Promega, Madison, WI). For the wound
healing assay, monolayers of mock-shRNA and DDX3 knockdown
MCF-7 cells in 6well plateswere scratched along a diameter of thewell
with a sterile p200 pipette tip, followed by a wash to remove debris.
Images were taken at 10× magniﬁcation.
Sources of chemicals were: sodium butyrate, trichostatin A,
nicotinamide, valproic acid, lithium chloride, camptothecin, cytosine
β-D-arabino-furanoside (Ara-C) (Sigma, St. Louis, MO), bleomycin,
leptomycin B, and etoposide (Alexis Biochemicals, San Diego, CA). The
primers for PCR were from integrated DNA Technologies (Coralville,
IA). The following sources provided antibodies:β-actin (Sigma); CREB,
acetyl-histone H3, histone H3, and Snail (Cell Signaling Technology,
Beverly, MA); p53 E-cadherin (Transduction Laboratories, Lexington,
KY). DDX3 antibodies were prepared in the laboratory of Dr. T. Zhou
[22]. GSK3β-HRP conjugated antibody and all horseradish peroxidase
(HRP)-conjugated secondary reagents were purchased from Southern
Biotechnology Associates (Birmingham, AL).
2.2. siRNA and expression
Lentiviral mediated shRNA was performed using shRNA lentiviral
(pLKO.1-puro) plasmids (Sigma). The oligonucleotides containing
the DDX3 target sequence that were used are: sequence #1, 5′-
CCGGCCCTGCCAAACAAGCTAATATCTCGAGATATTAGCTT-
GTTTGGCAGGGTTTT and sequence #4, 5′-CCGGCGCTTGGAACAG-
GAACTCTTTCTCGAGAAAGAGTTCCTGTTCCAAGCGTTTT One 100 mm
dish of 293FT cells (Invitrogen) was co-transfected with 3 μg of the
pLKO.1-puro plasmids plus 3 μg each of the packaging vectors pLP1,
pLP2, and pLP/VSVG (Invitrogen) using lipofectamine 2000. The
media were changed approximately 16 h after transfection, and the
cells were cultured an additional 48–72 h. The media were then
collected, centrifuged at 3000 rpm for 5 min, and ﬁltered through a
0.45 μm ﬁlter. Experimental cells were incubated with the virus-
containing medium overnight in 6-well plates, the media were
changed, and cells were incubated for 24 h. Cells were transferred to
100 mm dishes and infected cells were selected by incubation in
puromycin (1 μg/ml).
For RT-PCR analysis, RNA was isolated using Trizol (Invitrogen)
according to manufacturer's protocol. The RNA was quantiﬁed using a
Nano-drop spectrophotometer. The RT-PCR reaction was performed
using the ImProm-II™ Reverse Transcription System (Promega)
according to the manufacturer's protocol. To analyze Snail RNA,
200 ng of RNAwas used in the reaction with the following primers 5′-
TCCCGGGCAATTTAACAATG-3′ and 5′-TGGGAGACACATCGGTCAGA-3′
for 32 cycles. To analyze 18S RNA, 200 ng of RNA was used with
the following primers 5′-GAGCGAAAGCATTTGCCAAG-3′ and 5′-GGCATCGTTTATGGTCGGAA-3′ for 20 cycles. The resulting cDNA was
then visualized on a 2% agarose gel containing ethidium bromide and
imaged on a multi-imager (Bio-Rad). For mRNA quantitation, real-
time PCR was performed with the LightCycler system (Roche
Molecular Biochemicals) using the SYBR green ﬂuorophore.
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Cells were washed twice with PBS and lysed in lysis buffer (20 mM
Tris, pH 7.5, 150 mM NaCl, 2 mM EDTA, 1 mM sodium orthovanadate,
100 μM phenylmethylsulfonyl ﬂuoride, 10 μg/ml leupeptin, 10 μg/ml
aprotinin, 5 μg/ml pepstatin, 50 mMNaF, 1 nM okadaic acid, 1% Triton
X-100, and 10% glycerol). The lysateswere incubated for 30 min on ice,
centrifuged at 20,800 × g for 15 min, and supernatants were collected.
To immunoblot acetylated histones, cells were harvested, washed
twicewith PBS, and resuspended in triton extraction buffer containing
0.5% TritonX100 (v/v), 2 mM phenylmethylsulfonyl ﬂuoride (PMSF),
and 0.02% (w/v) NaN3. Lysed cells were incubated on ice for 10 min at
4 °C, then washed with extraction buffer and centrifuged. The pellet
was resuspended in 0.2 N HCl, incubated overnight at 4 °C, and theFig. 2.DDX3 knockdown alters Snail levels and cell morphology, proliferation, andmigration.
wild-type (WT), DDX3 knockdown (KD), or mock knockdown (using a control shRNA) cells.
DDX3 knocked down. (B) DDX3 was knocked down by two different sequences of shRNA in
shRNA (Control) and DDX3 knockdown (using clone #4 described in B) MCF-7 cells. (D)
described in B) HeLa cells (3000 cells), MDA-MB-231 cells (1000 cells), and MCF-7 cells (300
n=3, *pb0.05 compared with wild-type cells. (E) Proliferation was measured in MCF-7 c
Means±SEM, n=3, *pb0.05. (F) The wound healing assay was performed in mock-shRN
scratch was implemented and the cells were imaged immediately and after incubation fosupernatant was used for immunoblotting. Protein concentrations
were determined using the bicinchoninic method (Pierce, Rockford,
IL). Cell lysates were mixed with Laemmli sample buffer and placed
in a boiling water bath for 5 min. Proteins were resolved in SDS-
polyacrylamide gels and transferred to nitrocellulose. Blots were
probed with the indicated antibodies and were developed using
horseradish peroxidase-conjugated goat anti-mouse or goat anti-
rabbit IgG, followed by detection with enhanced chemiluminescence.
2.4. Human GBM tissue samples
The Brain Tumor Tissue Core Facility of the UAB Brain Tumor
SPORE provided patient tumor specimens that had been collected and
archived under an IRB approved protocol (X050415007). Freshly(A) E-cadherin, DDX3, Snail, and β-actin levels were immunoblotted in HeLa andMCF-7
Dark exposures of ﬁlms were used to allow detection of low levels of Snail in cells with
MCF-7 cells, and DDX3 and Snail levels were immunoblotted. (C) Morphology of mock-
Proliferation was measured in wild-type and DDX3 knockdown (KD; using clone #4
0 cells; using clone #4 described in B), along with a mock-shRNA control. Means±SEM,
ells with control mock-shRNA or clones #1 or #4 DDX3 knockdown described in (B).
A (Control) and DDX3 knockdown (using clone #4 described in B) MCF-7 cells. The
r 2 days.
Fig. 2 (continued).
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debrided of blood clots and any charred or obviously necrotic
portions, cut into 75–100 mg samples and snap-frozen in sterile
cryovials in liquid nitrogen. Tissues were stored in the vapor phase of
liquid nitrogen until used. Distribution of patients by race and gender
are shown in Table 1. The average age of these patients at surgery was
57.7±13.1 years. All but ﬁve of the tumor specimens were from an
initial resection. The ﬁve exceptions (Fig. 7: #2, 12, 15, 29, 31) were
derived from surgical resections of recurrent GBM.
3. Results
3.1. HDAC inhibitors increase the expression level of Snail
Snail levels were compared in nine cell lines and were found to be
highest in HeLa and MDA-MB-231 cells (Fig. 1A). We tested if HDAC
inhibitors altered Snail levels in each of the two cell lines with the
highest Snail levels. Nuclear levels of Snail were increased in HeLa
cells (Fig. 1B) and MDA-MB-231 cells (Fig. 1C) following 3 h
treatments with the HDAC inhibitors valproic acid (5 mM), sodium
butyrate (5 mM) (NaBu) or trichostatin A (1 μM) (TSA), but not
nicotinamide (5 mM), and nicotinamide did not alter the response toTSA. This indicates Snail regulation by class I or II HDACs inhibited by
valproic acid, NaBu, and TSA, but not by the class III sirtuins inhibited
by nicotinamide [23]. Pretreatment with the protein synthesis
inhibitor cycloheximide (40 μg/ml) for 1 h completely blocked the
increased Snail levels induced by treatment with HDAC inhibitors
(Fig. 1D). None of the HDAC inhibitors affected the level of DDX3. We
examined the effects of HDAC inhibitors on Snail mRNA levels.
Treatment with valproic acid, NaBu or TSA each increased Snail mRNA
levels in HeLa, SH-SY5Y and MCF-7 cells, although the response to
valproic acid was much less than the others (Fig. 1E).
3.2. Knockdown of DDX3 reduces Snail and alters cell morphology,
proliferation and migration
In accordance with a previous report that DDX3 suppressed
E-cadherin expression in MCF-10A cells [20], knocking down DDX3
increased E-cadherin levels in both HeLa and MCF-7 cells (Fig. 2A).
This suggested that DDX3 knockdown may reduce Snail levels since
Snail is a transcriptional repressor of E-cadherin [1,3,4]. In support of
this hypothesis, Snail levels were decreased in both HeLa andMCF-7
cells with DDX3 knocked down (Fig. 2A). Using two different shRNA
sequences to knockdown DDX3 levels in MCF-7 cells revealed that
Fig. 3. DDX3 is required for HDAC inhibitor-induced Snail expression. (A) Mock-shRNA (Ctl) or DDX3 knockdown (KD) MCF-7 cells were treated with HDAC inhibitors 5 mM NaBu,
or 1 μM TSA for 4 h, and then the levels of Snail, DDX3 and β-actin were measured. (B) Snail and 18S mRNA levels were measured in mock-shRNA (Ctl) or DDX3 knockdown MCF-7
cells after treatment with 5 mM NaBu or 1 μM TSA for 3 h. (C) Real time PCR was used to measure Snail and 18S mRNA levels in MCF-7 mock-shRNA and DDX3 knockdown cells
after treatment with 5 mM NaBu or 1 μM TSA for 3 h. Quantitative values are from NaBu or TSA treatment of DDX3 knockdown cells compared with mock-shRNA MCF-7 cells.
Means±SEM, n=3, *pb0.05. (D) Acetyl-histone H3 and total histone H3 levels were immunoblotted after mock-shRNA or DDX3 knockdown MCF-7 cells were treated with 5 mM
NaBu for 4, 5, or 6 h. (E) Mock-shRNA and DDX3 knockdown MCF-7 cells were treated with lithium (20 mM) for 30 min, 5.5 h, with lithium for 30 min followed by the addition of
10 μM MG132 during the last 5 h, or MG132 for 5 h, and DDX3, Snail, phospho-serine9-GSK3β, and β-actin levels were measured. (F) Mock-shRNA and DDX3 knockdown MCF-7
cells as described in (E) were pretreated with lithium (20 mM) for 30 min, followed by treatment with 5 mM NaBu or 1 μM TSA for 4 h, and Snail and β-actin levels were measured.
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extent of knockdown of the level of DDX3 (Fig. 2B). Thus, down-
regulation of DDX3 caused a corresponding decrease in the basal
level of Snail. We were also interested in testing if overexpression of
DDX3 altered Snail levels. However, we were unable to generate
HeLa, MCF-7, HEK293, NIH3T3, or SH-SY5Y cells that stably
overexpress DDX3, and transient overexpression of DDX3 in MCF-7 cells resulted in only a 2-fold increase in the level of DDX3. This
modest DDX3 overexpression in MCF-7 cells did not increase basal
or stimulated levels of Snail (Supplemental Figure 1). Thus, although
DDX3 is required to support Snail levels, a modest increase in the
level of DDX3 is not alone sufﬁcient to increase the level of Snail.
Snail regulates EMT, and examination of the morphology of MCF-7
cells in which DDX3 had been knocked down demonstrated
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adhesion, which correlated with the reduced Snail levels induced by
knocking down DDX3 (Fig. 2C). Snail also promotes cell proliferation
[24], and the proliferation of HeLa, MDA-MB-231, and MCF-7 cells
was reduced by knocking down DDX3 levels (Fig. 2D). The anti-
proliferative effect correlated with the extent of DDX3 knockdown
(Fig. 2E). Thus, Snail and its regulation of E-cadherin and cellular
characteristics are supported by DDX3.
Since Snail regulates cellularmigration, the wound healing assaywas
performed to test if cell migration is regulated by DDX3. Mock-shRNA
controlMCF-7 cellsmigrated into the scratchedareawithin48 h (Fig. 2F).
In contrast, MCF-7 cells with DDX3 knocked down only minimally
migrated into the scratched area. Thus, the reduced levels of Snail in
cells with DDX3 knocked down correlate with reduced cell migration.
3.3. DDX3 is required for HDAC inhibitor-induced Snail expression
Since the basal level of Snail is supported by DDX3, we tested if
DDX3 is required for HDAC inhibitors to increase Snail expression. The
increased Snail levels induced by treating MCF-7 cells with NaBu or
TSA were greatly diminished in cells with DDX3 knocked down
(Fig. 3A), indicating that DDX3 is required for HDAC inhibitor-induced
increases in Snail. Measurements of Snail mRNA levels conﬁrmed thatFig. 4. Topoisomerase inhibitors increase Snail expression. (A) MCF-7 cells were treated
immunoblotted. (B) MCF-7, (C) SH-SY5Y, or (D)MDA-MB-231 cells, which express mutant p
free media for 2 h, and then Snail, p53, and β-actin levels were immunoblotted. (E) Cytosol
10 μM camptothecin for 2, 3, or 4 h. CREB was immunoblotted as a nuclear marker and α-tincreases induced by treatment with NaBu or TSA were diminished in
cells with DDX3 knocked down (Fig. 3B). Snail mRNA measured by
qRT-PCR demonstrated increases induced by NaBu and TSA treatment
were 28- and 26-fold, respectively, and these increases were
attenuated by ~60% in cells with DDX3 knocked down (Fig. 3C).
NaBu-induced acetylation of histone H3 was unaffected by knocking
down DDX3, excluding the possibility that DDX3 knockdown
inhibited histone acetylation (Fig. 3D).
Snail phosphorylation by GSK3 promotes its proteosomal degra-
dation [8], and GSK3 inhibitors were shown to increase Snail by both
translational [25] and post-translational regulation [8]. Therefore, we
tested if the inhibitory effect of knocking down DDX3 on Snail levels
could be due to promoting the actions of GSK3. Inhibition of GSK3 by
pretreatment of MCF-7 cells with the GSK3 inhibitor lithium for
30 min or 5.5 h alone had little effect on Snail levels in wild-type or
DDX3 knocked down MCF-7 cells, but augmented Snail accumulation
in cells treated with the proteasome inhibitor MG132 (Fig. 3E).
Increased serine9-phosphorylated GSK3β in lithium-treated cells
conﬁrmed that lithium inhibited GSK3 [26]. Pretreatment with
lithium to inhibit GSK3 did not alter either the increases in Snail
induced by NaBu or TSA or the reduction evident in cells with DDX3
knocked down (Fig. 3F), altogether indicating that the effect of DDX3
on HDAC inhibitor-induced Snail expression is independent of GSK3.with 100 μM etoposide for 5–24 h, and the levels of Snail, p53, and β-actin were
53, were treated with 10 μM camptothecin for 2, 3, or 4 h following incubation in serum-
ic and nuclear p53 and Snail levels were measured after MCF-7 cells were treated with
ubulin as a cytosolic marker.
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increase Snail expression level
Because HDAC inhibitors can cause DNA damage [27,28], we tested
if Snail levels were inﬂuenced by other DNA damaging agents. These
experiments showed that treatment with bleomycin, H2O2, or Ara-C
did not increase, and in some cases decreased, Snail levels, although
all of these agents caused DNA damage as indicated by increased
levels of p53 (Supplemental Figure 2). However, Snail levels increased
after treatment with the topoisomerase II inhibitor etoposide
(Fig. 4A), and treatment with the topoisomerase I inhibitor camp-
tothecin (10 μM) increased Snail levels in MCF-7 cells (Fig. 4B), SH-
SY5Y cells (Fig. 4C), and MDA-MD-231 cells, which express mutant
p53, (Fig. 4D) in a time-dependent manner that matched p53
accumulation. Nuclear Snail, as well as nuclear p53, levels increased
after camptothecin treatment, whereas cytosolic Snail and p53 levels
were very low (Fig. 4E). The camptothecin-induced increase in Snail
protein level was mirrored by increased Snail mRNA levels in both
MCF-7 and SH-SY5Y cells (Fig. 5A). qRT-PCR measurements demon-
strated that camptothecin treatment increased Snail mRNA levels
by 22-fold in MCF-7 cells after treatment for 4 h (Fig. 5B). Since
camptothecin-induced DNA damage activates the transcription factor
p53, we tested if p53 regulates camptothecin-induced increased Snail
expression in H1299 p53-null cells that inducibly express p53 [29].Fig. 5. Camptothecin increases Snail mRNA levels. (A) Snail and 18SmRNA levels weremeasu
(B) Real time PCR was used to measure Snail and 18S mRNA levels inMCF-7 cells after treatm
with or without inducibly expressing p53 for 24 h, followed by treatment with 10 μM campCamptothecin (10 μM) treatment increased Snail levels equivalently
in H1299 cells with or without induced expression of p53 (Fig. 5C),
indicating that p53 does not mediate the upregulation of Snail caused
by camptothecin treatment.
3.5. DDX3 knockdown reduces Snail levels induced by camptothecin
We tested if the camptothecin-induced increase in Snail levels
was dependent on DDX3. Treatment of MCF-7 cells with 10 μM
camptothecin increased the level of Snail, but this was attenuated in
cells with DDX3 knocked down (Fig. 6A). The level of GSK3βwas used
as a loading control and to demonstrate that neither camptothecin nor
DDX3 regulated GSK3β levels. Measurements of Snail mRNA revealed
increases induced by camptothecin treatment, but knocking down
DDX3 did not alter the camptothecin-induced increase in the Snail
mRNA level (Fig. 6B), indicating that DDX3 supports the accumulation
or stabilization of Snail protein instead of transcriptional expression
after camptothecin treatment.
Since Snail can be stabilized by inhibiting its nuclear export, which
is mediated by a CRM1-dependent mechanism [7], we tested if the
depletion of nuclear Snail caused by DDX3 knockdown was affected
by treatment with leptomycin B, an inhibitor of CRM1-mediated
nuclear export. After leptomycin B treatment (20 ng/ml; 5 h), the
nuclear Snail level slightly increased in wild-type MCF-7 cells, but inred inMCF-7 and SH-SY5Y cells after treatment with 10 μMcamptothecin for 2, 3, or 4 h.
ent with 10 μM camptothecin. Means±SEM, n=3. (C) H1299 p53-null cells were used,
tothecin for 2 or 4 h, and Snail, p53, and β-actin levels were measured.
Fig. 6.DDX3 knockdown-induced inhibition of camptothecin-induced Snail is a post-translational effect. (A) Mock-shRNA (Ctl) and DDX3 knockdown (KD)MCF-7 cells were treated
with 10 μM camptothecin for 2 or 3 h, and Snail, DDX3, and GSK3β in cell lysates were immunoblotted. (B) Snail and 18S mRNA levels were measured in mock-shRNA or DDX3
knockdown MCF-7 cells after treatment with 10 μM camptothecin for 2 or 3 h. (C) Cytosolic and nuclear fractions were prepared from wild-type (WT) or DDX3 knockdown MCF-7
cells after treatment with or without leptomycin B (20 ng/ml) for 5 h, and the levels of Snail, and DDX3 in both fractions weremeasured. Fractions were also immunoblotted with the
cytosolic marker tubulin and the nuclear marker CREB. (D) Nuclear fractions were prepared from wild-type and DDX3 knocked down MCF-7 cells, DDX3 was immunoprecipitated,
and DDX3 and Snail were immunoblotted.
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replenished to nearly the level attained in wild-type cells (Fig. 6C).
This suggested that knocking down DDX3 facilitated the nuclear
export of Snail which was inhibited by leptomycin B, indicating that
DDX3 promotes retention of Snail in the nucleus to support its
accumulation. The possibility that this may be due to an interaction
between DDX3 and Snail in the nucleus was examined by measuring
their co-immunoprecipitation from nuclear fractions. In wild-type
MCF-7 cells, Snail was detected in immunoprecipitants of DDX3,
whereas as a control no Snail was detected after immunoprecipitating
DDX3 from MCF-7 cells with DDX3 knocked down (Fig. 6D).
3.6. DDX3 and Snail levels in human GBM
To test if DDX3may inﬂuence Snail in gliomas, wemeasured DDX3
and Snail levels in glioblastoma multiforme (GBM) tumor biopsy
samples. Analysis of 31 samples revealed a statistically signiﬁcant
(p=0.001; chi-square analysis) correlation between DDX3 and Snail
(Fig. 7). Ten samples expressed high levels of both DDX3 and Snail,
and neither DDX3 nor Snail was detected in 14 samples. DDX3 but not
Snail was detected in 6 samples, indicating that DDX3 is not sufﬁcient
alone to increase Snail expression. Only 1 sample (#24; primary GBM,
51 yo WM) expressed Snail but not DDX3, indicating that only rarely
does Snail accumulate in the absence of DDX3.4. Discussion
Snail is a transcription factor with an important role in regulating
cancer progression, especially invasion and metastasis [1], but few
mechanisms have been identiﬁed that regulate Snail. This study found
that DDX3 is essential for maintenance or upregulation of Snail levels,
as both basal levels of Snail and increased Snail levels induced by
treatment with HDAC inhibitors or by camptothecin were reduced in
cells with the level of DDX3 knocked down. Furthermore, the levels of
Snail and DDX3 were signiﬁcantly correlated in a panel of glioblas-
toma samples. These ﬁndings demonstrate that DDX3 contributes to
supporting the levels of Snail, which may have a regulatory role
during cancer progression.
This study ﬁrst found that DDX3 contributes to supporting basal
levels of Snail, as knockdown of DDX3 in both breast cancer cells and
cervical cancer cells reduced Snail levels in the absence of other
treatments. Cells with DDX3 levels knocked down displayed signif-
icantly lower proliferation rates than control cells, cell adhesion
appeared to be increased, as was the level of E-cadherin, and cell
motility was greatly decreased after DDX3 knockdown. These results
complement a previous report that overexpression of DDX3 induced
EMT and increased motility and invasion [20]. Conversely, it was
difﬁcult to obtain cells with high levels of overexpressed DDX3,
suggesting that overexpressed DDX3 is unstable or toxic. A modest
Fig. 7. Correlation between DDX3 and Snail levels in human glioblastoma samples. Snail
and DDX3 levels were measured in 32 glioblastoma samples. Sample 15 was excluded
from the analysis because of the absence of the β-actin loading control. The relative
relationships between the expression of DDX3 and Snail were calculated as a percent of
total human glioblastoma samples analyzed. Evaluation by the chi-square test
demonstrated a signiﬁcant correlation (p=0.001) between Snail and DDX3 levels.
446 M. Sun et al. / Biochimica et Biophysica Acta 1813 (2011) 438–447increase of DDX3 after overexpression in MCF-7 cells did not increase
Snail levels, indicating that DDX3 alone is not sufﬁcient to increase
Snail levels, consistent with ﬁndings in GBM that DDX3 is expressed in
some cells in the absence of detectable Snail, whereas Snail expression
requires DDX3. Together with previous evidence linking DDX3 to
signaling events important in carcinogenesis and chemotherapy
[18,20,21], these results further strengthen this connection and
suggest that supporting Snail expression contributes to the capacity
of DDX3 to regulate cancer progression.
Treatment with HDAC inhibitors caused rapid and large increases
in Snail levels in several types of cells, and these increases correlated
with increased Snail mRNA levels. This extends a previous report that
the HDAC inhibitor TSA increased Snail levels in MCF-7 cells [9].
Depletion of DDX3 greatly reduced HDAC inhibitor-induced increases
in Snail protein and mRNA levels, indicating that DDX3 supports
the transcriptional upregulation of Snail in the presence of HDAC
inhibitors. Moreover, Snail expression and protein levels supported by
DDX3 were independent of GSK3, an enzyme reported to regulate
both Snail stability and expression [7–9]. Along with previous reports
that DDX3 is partially nuclear and associates with the Sp1 transcrip-
tion factor [14,16–18], these ﬁndings raise the possibility that nuclear
DDX3 modulates the transcriptional machinery regulating Snail
expression, the subject of future investigations.Since HDAC inhibitors can induce DNA damage and cell death in
many types of cancer cells [31,32], and γ-irradiation increased Snail
levels [10], we tested if the increased expression of Snail induced by
HDAC inhibitors may be related to DNA damage. This was tested by
measuring Snail levels after treatments with several agents that
induce DNA damage by different mechanisms. We found that the
topoisomerase inhibitors camptothecin and etoposide increased Snail
levels, but increased Snail expression was not a general response to
DNA damage because other DNA damaging treatments, including
bleomycin, H2O2, and Ara-C, did not increase Snail levels. In agree-
ment with this selective up-regulation of Snail, the camptothecin-
induced up-regulation of Snail was independent of p53. Increased
Snail expression induced by the chemotherapeutic agent camptothe-
cin [30] was robust and evident in several cell types, a disturbing
ﬁnding since it raises the possibility that cancer cells surviving
camptothecin-induced death during chemotherapy may up-regulate
Snail levels and thereby increase the potential for metastasis. Thus,
not only does Snail counteract apoptotic programs activated by DNA
damaging agents [31,32], but Snail is up-regulated following camp-
tothecin treatment. Knocking down DDX3 reduced the camptothecin-
inducedup-regulation of Snail, but surprisingly considering our results
with HDAC inhibitors, this was not a transcriptional effect of DDX3 but
only was evident upon measuring Snail protein levels. This depletion
of Snail with DDX3 knocked down was reversed by blocking nuclear
export of Snail, raising the possibility that DDX3 may promote Snail
stabilization by reducing its nuclear export to the proteasome. Thus,
DDX3 supports Snail expression, as evident in basal conditions and in
the responses to HDAC inhibitors. However, camptothecin-induced up-
regulation of Snail expression eliminated the effect of DDX3 on Snail
expression, but in this condition DDX3 affected the protein levels of
Snail, possibly due to the direct interaction of DDX3 with Snail in the
nucleus evident in co-immunoprecipitation experiments.
Analysis of human GBM tissue samples further supported the
hypothesis that DDX3 contributes to increased Snail levels. Samples
with high Snail levels always expressed high DDX3 levels. In this
group of GBM tumors, Snail was only rarely (1 of 31 samples) detected
in the absence of DDX3, although DDX3 could be detected in the
absence of Snail, suggesting DDX3 is not sufﬁcient, but may be
required, to support Snail protein accumulation.
In summary, the results reported here reveal that DDX3 supports
the expression of Snail, a transcription factor important in cancer
progression. By supporting increased cellular Snail levels, DDX3
inﬂuences cell proliferation and motility. Thus, these ﬁndings add to
the evidence that DDX3 plays important roles in processes that are
associated with carcinogenesis and chemotherapy.
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